Related Experiment Video
Updated: Jan 22, 2026

Systemic Delivery of MicroRNA Using Recombinant Adeno-associated Virus Serotype 9 to Treat Neuromuscular Diseases in Rodents
Published on: August 10, 2018
The Emerging Role of microRNAs in Polyglutamine Diseases
1Department of Neurology, Shengjing Hospital of China Medical University, Shenyang, China.
Abstract:
MicroRNAs (miRNAs) are small non-coding molecules that regulate a large amount of post-transcriptional repressor genes by recognizing semi-complementary target sequences that are normally located in the 3' UTR of the mRNA. Altered expression of miRNA has been related to several pathological processes, including polyglutamine (Poly Q) diseases. Specific expression patterns in the circulating fluids and brain parenchyma have been speculated as potential biomarkers for Poly Q disease diagnosis and prognosis. Several miRNAs have been consistently identified in diseases including Huntington's disease (HD) and spinocerebellar ataxia (SCA). In our review, we describe the emerging role of miRNAs in Poly Q diseases and provide an overview on general miRNA biology, implications in pathophysiology, and their potential roles as future biomarkers and applications for therapy.
Insights
MicroRNAs (miRNAs) play a role in PolyQ diseases like Huntington's disease. Their altered expression suggests potential as biomarkers for diagnosis and therapy.
Area of Science:
- Molecular Biology
- Genetics
- Neuroscience
Background:
- MicroRNAs (miRNAs) are small non-coding RNA molecules regulating gene expression post-transcriptionally.
- Aberrant miRNA expression is implicated in various pathological conditions, including polyglutamine (Poly Q) diseases.
- Specific miRNA profiles in bodily fluids and brain tissue are potential diagnostic and prognostic biomarkers for Poly Q diseases.
Purpose of the Study:
- To review the emerging role of miRNAs in Poly Q diseases.
- To provide an overview of miRNA biology and their pathological implications.
- To explore the potential of miRNAs as biomarkers and therapeutic targets.
Main Methods:
- Literature review of studies on miRNAs and Poly Q diseases.
- Analysis of miRNA expression patterns in relevant disease models and patient samples.
- Synthesis of current knowledge on miRNA function, disease association, and therapeutic potential.
Main Results:
- Consistent identification of specific miRNAs in Poly Q diseases such as Huntington's disease (HD) and spinocerebellar ataxia (SCA).
- Evidence suggests miRNAs are involved in the pathophysiology of Poly Q diseases.
- Circulating and brain-specific miRNAs show promise as biomarkers.
Conclusions:
- miRNAs represent a significant area of research in Poly Q diseases.
- Further investigation into miRNA biomarkers could improve diagnosis and prognosis.
- miRNAs hold potential for novel therapeutic strategies in Poly Q diseases.
Related Concept Videos
MicroRNAs
MicroRNAs
Emerging Adulthood
Introduction Cardiac Emergencies
Applications of GIS: Disaster Management and Emergency Response
The Role of Culture

